This page focuses on very early-onset ibd management—practical, evidence-based guidance for diagnosing, treating, nourishing, and supporting day-to-day life in children with IBD. It emphasizes family partnership, timely diagnosis, growth-promoting treatment, and strategies that families can implement at home and at school. By centering the child’s development and the family’s rhythm, this approach aims to reduce symptoms, protect growth, and improve quality of life. Diagnosis and treatment options in this context require a multidisciplinary team, including pediatric gastroenterologists, nutritionists, and geneticists. Evaluation may combine stool biomarkers, imaging, endoscopy, and, when onset is very early, genetic testing to identify monogenic forms that may need targeted therapies. Treatments are tailored to disease type and individual needs, with a focus on inducing remission while sparing steroids where possible and supporting long-term growth, development, and school participation. Ongoing monitoring, vaccination updates, and psychosocial support are integral to effective VEO-IBD management. Nutrition and day-to-day life are central to success. Nutritional strategies—such as exclusive enteral nutrition when appropriate—can help induce and sustain remission while promoting growth and resilience. Practical dietary planning emphasizes energy and protein adequacy, balanced micronutrients, and approachable meals that fit into family routines and school schedules. Parents and caregivers benefit from planning that reduces stress, supports regular meals and hydration, and accommodates variability in symptoms so that daily activities remain as normal as possible. Tech-enabled insights can enhance clinical care in very early-onset ibd management. InnerBuddies offers a modular Gut Health Operating System to support data-driven decisions in pediatric gut health. The system provides a Gut Microbiome Health Index from 0 to 100, built on a collaboration with EAFIT University in Colombia, plus a curated set of bacteria abundances and functional pathways that show how a child’s microbiome compares to a healthy cohort. It also includes Target Group analyses and personalized nutrition and probiotic recommendations tailored to the individual gut microbiome. For families exploring microbiome insights, you can explore the InnerBuddies microbiome test and, with ongoing guidance, the InnerBuddies Gut Health Membership. Providers and programs interested in collaboration can learn more on the InnerBuddies B2B page. InnerBuddies also offers direct-to-consumer gut test solutions, with all B2B capabilities available to consumers.